United Therapeutics Corp (UTHR)

08:19 AM

United Therapeutics’ Promising Study on Inhaled Treprostinil for Lung Disease - TipRanks

08:19 AM

07:08 AM

United Therapeutics’ Promising Phase 3 Study on Inhaled Treprostinil for Pulmonary Fibrosis - TipRanks

07:08 AM

05:52 AM

United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - TipRanks

05:52 AM

05:22 AM

United Therapeutics’ Xenokidney Study: A New Hope for ESRD Patients - TipRanks

05:22 AM

04:27 AM

United Therapeutics’ DeciPHer-ILD Study: A Closer Look at PH-ILD Patient Registry - TipRanks

04:27 AM

02:55 AM

United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - TipRanks

02:55 AM

01:55 AM

United Therapeutics Advances Ralinepag Study for PAH Treatment - TipRanks

01:55 AM

04:31 AM

Will United Therapeutics Corporation stock benefit from upcoming earnings reports2025 Risk Factors & Reliable Breakout Forecasts - newser.com

04:31 AM

04:00 AM

What margin trends mean for United Therapeutics Corporation stockMarket Growth Review & Consistent Profit Trading Strategies - newser.com

04:00 AM

Oct 26, 2025

Nepsis Liquidates $14 Million CyberArk Software (NASDAQ: CYBR) Position: Did the Stock Soar Too High, Too Fast? - The Motley Fool

Oct 26, 2025

Oct 26, 2025

Published on: 2025-10-26 13:21:57 - newser.com

Oct 26, 2025

Oct 26, 2025

Will United Therapeutics Corporation benefit from macro trendsMarket Weekly Review & Precise Swing Trade Alerts - newser.com

Oct 26, 2025

Oct 25, 2025

How United Therapeutics Corporation (UTH) stock benefits from digital adoptionJuly 2025 Catalysts & Reliable Entry Point Trade Alerts - newser.com

Oct 25, 2025

Oct 22, 2025

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 22, 2025

Oct 22, 2025

United Therapeutics (UTHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance

Oct 22, 2025

Oct 21, 2025

What data driven models say about United Therapeutics Corporation’s future2025 Sector Review & Fast Moving Stock Watchlists - newser.com

Oct 21, 2025

Oct 21, 2025

Risk adjusted return profile for United Therapeutics Corporation analyzedJuly 2025 Volume & Fast Gain Swing Trade Alerts - newser.com

Oct 21, 2025

Oct 21, 2025

What makes United Therapeutics Corporation stock attractive to growth fundsTrade Risk Assessment & Precise Trade Entry Recommendations - newser.com

Oct 21, 2025

Oct 20, 2025

United Therapeutics Executives Sell Shares - TradingView

Oct 20, 2025

Oct 20, 2025

United Therapeutics EVP & General Counsel Sells 11,000 Shares - TradingView

Oct 20, 2025

Oct 20, 2025

Why United Therapeutics Corporation (UTH) stock gets analyst attention2025 Buyback Activity & Reliable Momentum Entry Alerts - newser.com

Oct 20, 2025

Oct 18, 2025

United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo

Oct 18, 2025

Oct 18, 2025

Will United Therapeutics Corporation (UTH) stock attract long term capital inflowsJuly 2025 Setups & Weekly High Potential Alerts - Trung tâm Dự báo KTTV quốc gia

Oct 18, 2025

Oct 16, 2025

Jefferies Reiterates Buy Rating on United Therapeutics (UTHR) Amid Patent Case - Insider Monkey

Oct 16, 2025

Oct 15, 2025

United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 15, 2025

Oct 13, 2025

PH-ILD hospitalization data on inhaled treprostinil — United Therapeutics at CHEST 2025 - Stock Titan

Oct 13, 2025

Oct 13, 2025

Callan Family Office LLC Increases Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 13, 2025

Oct 12, 2025

United Therapeutics (FRA:UTH) Gross-Profit-to-Asset % : 35.18% (As of Jun. 2025) - GuruFocus

Oct 12, 2025

Oct 12, 2025

UTHR (United Therapeutics) Cyclically Adjusted PB Ratio : 4.79 (As of Oct. 12, 2025) - GuruFocus

Oct 12, 2025

Oct 12, 2025

Inspire Investing LLC Trims Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 12, 2025

Oct 12, 2025

UTHR (United Therapeutics) 5-Year RORE % : 17.31% (As of Jun. 2025) - GuruFocus

Oct 12, 2025

Oct 12, 2025

UTHR (United Therapeutics) Revenue per Share : $63.53 (TTM As of Jun. 2025) - GuruFocus

Oct 12, 2025

Oct 09, 2025

Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Oct 09, 2025

Oct 09, 2025

United Therapeutics Corp. Hits New 52-Week High of $455.26 - Markets Mojo

Oct 09, 2025

Oct 09, 2025

United Therapeutics Corp. Hits New 52-Week High of $459.48 - Markets Mojo

Oct 09, 2025

Oct 08, 2025

United Therapeutics Corp. Hits New 52-Week High of $455.00 - Markets Mojo

Oct 08, 2025

Oct 08, 2025

United Therapeutics (NASDAQ:UTHR) Sets New 52-Week HighHere's What Happened - MarketBeat

Oct 08, 2025

Oct 07, 2025

Insider Selling: United Therapeutics (NASDAQ:UTHR) COO Sells 22,500 Shares of Stock - MarketBeat

Oct 07, 2025

Oct 06, 2025

QRG Capital Management Inc. Raises Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 06, 2025

Oct 05, 2025

Is There Still an Opportunity in United Therapeutics After Its 25.8% Year to Date Surge? - simplywall.st

Oct 05, 2025

Oct 04, 2025

Polaris Capital Management LLC Reduces Stock Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 04, 2025

Oct 04, 2025

Hilltop National Bank Takes $341,000 Position in United Therapeutics Corporation $UTHR - MarketBeat

Oct 04, 2025

Oct 04, 2025

What Catalysts Are Reshaping the Narrative for United Therapeutics This Year? - Yahoo Finance

Oct 04, 2025

Oct 03, 2025

A Look at United Therapeutics (UTHR) Valuation as Tyvaso Shows Breakthrough Results in Late-Stage IPF Trial - simplywall.st

Oct 03, 2025

Oct 03, 2025

How Positive TETON-2 Results for Tyvaso Have Changed United Therapeutics' (UTHR) Investment Story - simplywall.st

Oct 03, 2025

Oct 03, 2025

News impact scoring models applied to United Therapeutics CorporationPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Robeco Institutional Asset Management B.V. Boosts Stake in United Therapeutics Corporation $UTHR - MarketBeat

Oct 03, 2025

Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD - Investing.com

Oct 02, 2025

Oct 02, 2025

United Therapeutics stock hits all-time high at 442.02 USD By Investing.com - Investing.com South Africa

Oct 02, 2025

Oct 02, 2025

United Therapeutics rides Tyvaso optimism as IPF trial gains momentum - S&P Global

Oct 02, 2025

Oct 02, 2025

TD Cowen maintains Buy rating on United Therapeutics stock, citing IPF opportunity - Investing.com

Oct 02, 2025

Oct 02, 2025

Jefferies reiterates Buy rating on United Therapeutics stock amid patent case - Investing.com

Oct 02, 2025

Oct 02, 2025

UBS maintains United Therapeutics stock Buy rating amid patent litigation By Investing.com - Investing.com Canada

Oct 02, 2025

Oct 01, 2025

United Therapeutics COO sells $9.49m in UTHR stock By Investing.com - Investing.com South Africa

Oct 01, 2025

Oct 01, 2025

United Therapeutics COO sells $9.49m in UTHR stock - Investing.com India

Oct 01, 2025